High‐level expression of full‐length antibodies using trans‐complementing expression vectors
Authors:
- 17 October 2003
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 84 (4) , 439-444
Abstract
Recombinant antibodies are increasingly used as therapeutics for a wide variety of diseases. Generation of cell lines expressing high levels of recombinant antibody typically requires labor‐intensive cloning and screening steps. We describe a mammalian expression system for the high‐level production of full‐length antibody molecules. It has been shown that the dihydrofolate reductase (DHFR) selectable marker can be divided into two fragments that, with the aid of a leucine zipper, can re‐associate to form an active molecule. Using bicistronic vectors, we linked the expression of each antibody chain to the expression of a DHFR fragment. Survival in selective media requires expression of both DHFR fragments that, by virtue of these vectors, also selects for the expression of both antibody chains. Initial pools produced 5 µg of Ab/106 cells/d (qP = µg/106 cells/d). Expression of each antibody chain in conjunction with a portion of DHFR also leads to concurrent amplification of both antibody chains in the presence of methotrexate, a DHFR inhibitor, and results in a two‐ to fivefold increase in antibody production with basal qPs ranging from 10–25 ug/106 cells/d. Shake‐flask cultures of amplified pools produced up to 600 mg/L of antibody in 7 days. This system allows for rapid generation of antibodies without cloning and greatly simplifies selection of cell lines for the production of potential antibody therapeutics. © 2003 Wiley Periodicals, Inc. Biotechnol Bioeng 84: 439–444, 2003.Keywords
This publication has 15 references indexed in Scilit:
- Monoclonal antibodies in the clinicNature Biotechnology, 2001
- Key Determinants in the Occurrence of Clonal Variation in Humanized Antibody Expression of CHO Cells during Dihydrofolate Reductase Mediated Gene AmplificationBiotechnology Progress, 2001
- Therapeutic monoclonal antibodiesThe Lancet, 2000
- Relationship between recombinant activated protein C secretion rates and mRNA levels in baby hamster kidney cellsBiotechnology and Bioengineering, 1999
- Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by Northern blot and flow cytometry1This paper was presented at the American Chemical Society Spring National Meeting in San Francisco, April 1997.1Journal of Biotechnology, 1999
- Improved bicistronic mammalian expression vectors using expression augmenting sequence element (EASE)Cytotechnology, 1998
- Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell lineCytotechnology, 1998
- Antibody Production in Chinese Hamster Ovary Cells Using an Impaired Selectable Marker1995
- Recent progress in understanding mechanisms of mammalian DNA amplificationCell, 1989
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987